FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/05/2025
Voltar para busca
Dado oficial do USPTO
ENDOSIGN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ENDOSIGN
ST13
US500000079371841Classe
9, 10, 42, 44
Pedido
79371841
Registro
7574681
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 42, 44
Data de depósito
05/05/2023
Data de registro
26/11/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/11/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
TURNER, JASON FITZGERALD
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Cyted Ltd
Representantes
Michael R. Friscia McCarter & English, LLP
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable and recorded computer software for cancer and gastrointestinal disease screening and diagnostic purposes in the medical field; downloadable and recorded computer software for use in patient treatment medical decision support systems; downloadable and recorded artificial intelligence software for cancer and gastrointestinal disease screening and diagnostic healthcare; downloadable and recorded machine learning software for analysis; downloadable and recorded machine learning software for healthcare; downloadable and recorded software for operational management for medical devices device (SaMD); downloadable electronic publications in the fields of medical and medical diagnostic assessment.
Classe 10
Medical apparatus and instruments for diagnostic and medical use; medical apparatus and instruments namely tissue collection apparatus and tissue analysis apparatus; diagnostic imaging apparatus for medical use; diagnostic testing apparatus in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing for medical use.
Classe 42
Medical research services; pharmacological medical research services; medical research laboratory services; software as a service SaaS services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; software creation; custom software development services; platform as a service (PAAS) featuring artificial intelligence computer software platforms for diagnosing cancer and gastrointestinal disease; computer aided pathological diagnostic testing services for diagnostic and treatment purposes; design and development of computer software; design and development of medical technology; design and development of computer software for use with medical technology; design and development of medical diagnostic apparatus; biomedical research services; electronic storage of medical records; calibration services for medical apparatus; providing scientific information in the field of medical disorders and their treatment.
Classe 44
Medical services; medical diagnostic services; medical testing; medical advisory services; medical treatment of cancer and gastrointestinal disease services; medical and healthcare clinics; providing medical information regarding testing and diagnosis of diseases and infections; providing medical information regarding diagnosis and treatment of diseases and infections.
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/04/2025
FIMP
FINAL DISPOSITION PROCESSED
22/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/02/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/11/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/09/2024
PUBO
PUBLISHED FOR OPPOSITION
24/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/08/2024
RFNT
REFUSAL PROCESSED BY IB
18/03/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/02/2024
RFRR
REFUSAL PROCESSED BY MPU
29/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2024
CNRT
NON-FINAL ACTION WRITTEN
07/02/2024
DOCK
ASSIGNED TO EXAMINER
31/01/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/08/2023
MAFR
APPLICATION FILING RECEIPT MAILED
20/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/06/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/06/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENDOSIGN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.